118 related articles for article (PubMed ID: 7323743)
1. Uninhibited neurogenic bladder treated with Prazosin.
Jensen D
Scand J Urol Nephrol; 1981; 15(3):229-33. PubMed ID: 7323743
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological studies of the uninhibited neurogenic bladder. III. The influence of adrenergic excitatory and inhibitory drugs on the cystometrogram of neurological patients with normal and uninhibited neurogenic bladder.
Jensen D
Acta Neurol Scand; 1981 Dec; 64(6):401-26. PubMed ID: 6127859
[TBL] [Abstract][Full Text] [Related]
3. Prazosin treatment of neurological patients with detrusor hyperreflexia and bladder emptying disability.
Petersen T; Husted SE; Sidenius P
Scand J Urol Nephrol; 1989; 23(3):189-94. PubMed ID: 2678426
[TBL] [Abstract][Full Text] [Related]
4. Lioresal in the treatment of neurogenic bladder dysfunction.
Kiesswetter H; Schober W
Urol Int; 1975; 30(1):63-71. PubMed ID: 1118949
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological studies of the uninhibited neurogenic bladder. I. The influence of repeated filling and various filling rates on the cystometrogram of neurological patients with normal and uninhibited neurogenic bladder.
Jensen D
Acta Neurol Scand; 1981 Sep; 64(3):145-74. PubMed ID: 7315190
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological studies of the uninhibited neurogenic bladder. II. The influence of cholinergic excitatory and inhibitory drugs on the cystometrogram of neurological patients with normal and uninhibited neurogenic bladder.
Jensen D
Acta Neurol Scand; 1981 Sep; 64(3):175-95. PubMed ID: 7315191
[TBL] [Abstract][Full Text] [Related]
7. Alfuzosin in the treatment of high leak-point pressure in children with neurogenic bladder.
Schulte-Baukloh H; Michael T; Miller K; Knispel HH
BJU Int; 2002 Nov; 90(7):716-20. PubMed ID: 12410754
[TBL] [Abstract][Full Text] [Related]
8. Long-term outcome of intravesical oxybutynin in children with detrusor-sphincter dyssynergia: with special reference to age-dependent parameters.
Humblet M; Verpoorten C; Christiaens MH; Hirche H; Jansen K; Buyse G; van Gool JD
Neurourol Urodyn; 2015 Apr; 34(4):336-42. PubMed ID: 24436114
[TBL] [Abstract][Full Text] [Related]
9. Clinical reevaluation of the effect of oxybutynin chloride on uninhibited neurogenic and reflex neurogenic bladder.
Kawabe K; Abe S; Kanda T; Tei K
Urol Int; 1986; 41(1):16-20. PubMed ID: 3962017
[TBL] [Abstract][Full Text] [Related]
10. Effect of flavoxate on hyperactive detrusor muscle.
Jonas U; Petri E; Kissel J
Eur Urol; 1979; 5(2):106-9. PubMed ID: 421699
[TBL] [Abstract][Full Text] [Related]
11. Effect of the alpha-adrenergic blocking agent thymoxamine on the neurogenic bladder and urethra.
Pedersen E; Tørring J; Klemar B
Acta Neurol Scand; 1980 Feb; 61(2):107-14. PubMed ID: 6446830
[TBL] [Abstract][Full Text] [Related]
12. The various types of neurogenic bladder dysfunction: an update of current therapeutic concepts.
Madersbacher H
Paraplegia; 1990 May; 28(4):217-29. PubMed ID: 2235029
[TBL] [Abstract][Full Text] [Related]
13. Effects of prazosin on isolated human urethra and in patients with lower motor neurons lesions.
Andersson KE; Ek A; Hedlund H; Mattiasson A
Invest Urol; 1981 Jul; 19(1):39-42. PubMed ID: 7251323
[TBL] [Abstract][Full Text] [Related]
14. The anticholinergic effects of dicyclomine hydrochloride in uninhibited neurogenic bladder dysfunction.
Fischer CP; Diokno A; Lapides J
J Urol; 1978 Sep; 120(3):328-9. PubMed ID: 682250
[TBL] [Abstract][Full Text] [Related]
15. Oral nitric oxide donors: a new pharmacological approach to detrusor-sphincter dyssynergia in spinal cord injured patients?
Reitz A; Knapp PA; Müntener M; Schurch B
Eur Urol; 2004 Apr; 45(4):516-20. PubMed ID: 15041118
[TBL] [Abstract][Full Text] [Related]
16. [Clinical effect of new alpha-adrenergic blocker on micturition disturbance of neurogenic bladder and lower urinary tract obstruction].
Takimoto Y; Kitamura K; Fuse T; Kawazoe K; Hirano D; Amagai T; Kiyotaki S
Hinyokika Kiyo; 1983 Feb; 29(2):255-63. PubMed ID: 6145342
[TBL] [Abstract][Full Text] [Related]
17. [Lantox treatment of neurogenic dysfunction of the bladder].
Maksimov VA; Saliukov RV; Martov AG; Borisik VI; Saliukova IuR
Urologiia; 2010; (5):53-6. PubMed ID: 21254642
[TBL] [Abstract][Full Text] [Related]
18. [Effects of alpha-1-blocking agent in the treatment of detrusor sphincter dyssynergia].
Gotoh M; Yoshikawa Y; Otani T; Kato T; Kobayashi M; Kato K; Saito M; Kondo A; Miyake K
Nihon Hinyokika Gakkai Zasshi; 1990 Dec; 81(12):1877-83. PubMed ID: 2292821
[TBL] [Abstract][Full Text] [Related]
19. The effect of terazosin on bladder function in the spinal cord injured patient.
Swierzewski SJ; Gormley EA; Belville WD; Sweetser PM; Wan J; McGuire EJ
J Urol; 1994 Apr; 151(4):951-4. PubMed ID: 7907374
[TBL] [Abstract][Full Text] [Related]
20. Botulinum toxin A detrusor injections in patients with neurogenic detrusor overactivity significantly decrease the incidence of symptomatic urinary tract infections.
Gamé X; Castel-Lacanal E; Bentaleb Y; Thiry-Escudié I; De Boissezon X; Malavaud B; Marque P; Rischmann P
Eur Urol; 2008 Mar; 53(3):613-8. PubMed ID: 17804150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
